X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DIABETES

期刊標題檢索 DIABETES 最新評論: What was your state of mind at that time? (2024-05-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DIABETES]您好,您是該頁面的第 101821 位訪客。

期刊簡介
期刊名稱DIABETES DIABETES
LetPub Score
9.0
50 ratings
Rate

Reputation
9.9

Influence
8.3

Speed
9.3

期刊簡稱DIABETES
ISSN0012-1797
E-ISSN1939-327X
h-index304
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.502.5411.360
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q117 / 244
Category: Medicine
Subcategory: Internal Medicine
Q113 / 167

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
官方網站http://diabetes.diabetesjournals.org/
在線稿件提交https://mc.manuscriptcentral.com/diabetes
開放訪問No
出版商American Diabetes Association Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1952
每年文章數152每年文章數趨勢
黃金OA百分比3.07%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ120/186
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0012-1797%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 37.5%
參考鏈接
相關期刊 【DIABETES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE190509
    Cell Metabolism129548
    JOURNAL OF PINEAL RESEARCH94433
    BIOLOGICAL TRACE ELEMENT RESEARCH92698
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81227
    ANTIOXIDANTS & REDOX SIGNALING79785
    DIABETES CARE73274
    BONE70356
    Obesity68258
    ENDOCRINOLOGY62697
  •  

    DIABETES DIABETES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [DIABETES] 的評論撰寫評論
作者: 截手爱敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-03 18:37:35 評論於
What was your state of mind at that time?
(0) 讚! | 截手爱敏

作者: 玄虚水秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-22 20:29:59 評論於
How long does it take from submission to acceptance?
(0) 讚! | 玄虚水秋

作者: Olive Kitto


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-20 18:30:38 評論於
Brother, does "with associated editor" mean it has been sent out for review? It's so slow, it's been almost a month already, and it's still with associated editor
(0) 讚! | Olive Kitto

作者: 努力啊大元彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-21 16:28:38 評論於
When do you need to submit the original data for the magazine, and what are the specific requirements?
(0) 讚! | 努力啊大元彤

作者: 西行寺运诚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-02 12:33:00 評論於
Submitted in November 2022, it has been 6 months and still inviting reviewers. 5 months in, reminders were sent with no response using a domestic email, but received a reply on the same day using an international email. Suggestions for reviewers were made for the editorial committee to review, but it has been a month and still no response. There is arrogance everywhere, so it's better to be cautious before submitting
(0) 讚! | 西行寺运诚

作者: 西行寺运诚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-02 10:53:19 評論於
Review Speed: 24.0 | Submission Success Rate: 5.0 
Experience Sharing: I have been submitting for 6 months since November 21, still inviting reviewers. At 5 months, I used my domestic unit email to urge for submission, with no response, changed to a foreign email, and got a response the same day, saying it will be processed as soon as possible. It has been a month and still in this state, showing arrogance everywhere. Be cautious when submitting
(0) 讚! | 西行寺运诚

作者: 代晴mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-16 23:46:16 評論於
Submitted on 2.7, rejected on 2.16. The rejection letter is a template and doesn't provide any feedback
(0) 讚! | 代晴mm

作者: 代晴mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-15 09:42:43 評論於
Received, thank you senior
(0) 讚! | 代晴mm

作者: 无相伊果


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-12 16:30:43 評論於
Rejecting a submission directly seems to be within 3 days. If it reaches the editorial review, it means passing the first round. Then it will be sent for further review
(0) 讚! | 无相伊果

作者: 代晴mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-08 08:38:32 評論於
The submission was made on February 7th, and on February 10th, it is still at the stage of being reviewed by the Editorial Committee. However, I am in a hurry to graduate now. I would like to ask experienced seniors, how long does it take for the editor to reject a submission directly?
(0) 讚! | 代晴mm

作者: 无相伊果


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 17:58:18 評論於
Hello, I am also in the stage of inviting reviewers. May I ask how long you waited afterwards?
(0) 讚! | 无相伊果

作者: 无相伊果


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 16:04:26 評論於
I'm the same. How did things turn out later?
(0) 讚! | 无相伊果

作者: Toby Nahum


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-17 16:12:00 評論於
Is there a high chance of diabetes being accepted after submission?
(0) 讚! | Toby Nahum

作者: 小困顿吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-16 18:06:48 評論於
Non-OA is also a one-page paper for $160
(0) 讚! | 小困顿吖

作者: Edison Partridge


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-24 15:49:03 評論於
Three months is too slow. What happened later?
(0) 讚! | Edison Partridge

作者: Edison Partridge


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-26 18:36:42 評論於
It has been two weeks and I am still awaiting admin processing. Can I send an email to follow up? It has not reached the editor yet, who should I contact?
(0) 讚! | Edison Partridge

作者: Edison Partridge


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-20 23:59:44 評論於
It has been a week since submission and the status has been Awaiting Admin Processing. Have the submission not reached the hands of the editor yet? How long will it take to receive a response?
(0) 讚! | Edison Partridge

作者: 烈焰赤奋若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-02 08:40:13 評論於
Thank you
(0) 讚! | 烈焰赤奋若

作者: Lynn Gibbon


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-09 22:50:43 評論於
You can apply for exemption from OA
(0) 讚! | Lynn Gibbon

作者: Lynn Gibbon


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-09 18:53:17 評論於
Editorial speed: 1.0 | Submission acceptance rate: 50.0 
Focus on research area: diabetes and obesity 
Experience sharing: Under review in just one week, feedback returned within a month. Currently in the process of revising manuscript
(0) 讚! | Lynn Gibbon

作者: Lynn Gibbon


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-09 15:04:23 評論於
It shouldn't happen
(0) 讚! | Lynn Gibbon

作者: mei110


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-08 09:51:42 評論於
2022-2-2 Submission
2022-2-10 Inviting reviewers
2022-2-11 Under review
2022-3-7 Major revision
Given three months of time, currently conducting experiments to address the comments from the reviewers. The reviewers' opinions are quite professional. Will share further updates in the future. Hoping for smooth progress ahead!
(0) 讚! | mei110

作者: 烈焰赤奋若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-13 17:17:55 評論於
Emphasis on research direction: Diabetic peripheral neuropathy
Sharing of experience: Never submitted before, planning to give it a try. Will a manuscript be rejected for lack of language editing?
(0) 讚! | 烈焰赤奋若

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:53:21 評論於
Most Chinese names are spelled out in full pinyin
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:21:57 評論於
The corresponding author of a SCI journal article does not necessarily have to be only one person, and there is no fixed standard for how many there should be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if the article lists multiple corresponding authors, the first corresponding author listed will automatically be chosen. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements— the number of corresponding authors listed in the article must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person listed first in the author column. However, in cases of collaboration between multiple authors, it is common to have co-first authors. There is no clear regulation on the number of co-first authors, and this is largely dependent on factors such as the workload and length of the paper, as well as the regulations of the publishing journal and the recognition of the affiliated units. Generally speaking, it is most common for an SCI paper to have 2-4 first authors
(0) 讚! | 维尔娜菲茨杰拉德

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [DIABETES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*